DrugPatentWatch Database Preview

Ipilimumab - Biologic Drug Details

« Back to Dashboard

Summary for ipilimumab

Tradenames:	1
Patents:	112
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for ipilimumab

Mechanism of Action	CTLA-4-directed Antibody Interactions
Physiological Effect	Increased T Lymphocyte Activation

US Patents for ipilimumab

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		OP NANO CO., LTD. (Taipei, TW) TRENDMED CO., LTD. (Beitou Dist., Taipei, TW)		RX		search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL)		RX		search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		University of Georgia Research Foundation, Inc. (Athens, GA)		RX		search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		Amgen Inc. (Thousand Oaks, CA)		RX		search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		AbbVie Stemcentrx LLC (North Chicago, IL)		RX		search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25		SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)		RX		search

International Patents for ipilimumab

Country	Document Number	Estimated Expiration
United Kingdom	201519761
South Korea	101762047
European Patent Office	3297630
Eurasian Patent Organization	201791706
Israel	252010
China	104185477

Supplementary Protection Certificates for ipilimumab

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2015040,C2049506	Lithuania		PRODUCT NAME: KOBICISTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/13/830/001 - 002 20130524
0860	Netherlands		PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN TENOFOVIR-ALAFENAMIDE, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER TENOFOVIR-ALAFENAMIDEFUMARAAT; REGISTRATION NO/DATE: EU/1/15/1061 20151123
C0078	France		PRODUCT NAME: COBICISTAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE COBICISTAT; REGISTRATION NO/DATE: EU/1/13/830/001-002 20130527
2017 00002	Denmark		PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF OG DARUNAVIR ELLER ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF, ISAER DARUNAVIRETHANOLAT; REG. NO/DATE: EU/1/14/967/001 20141121
2017 00003	Denmark		PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF OG ATAZANAVIR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER ATAZANAVIRSULFAT; REG. NO/DATE: EU/1/15/1025/001-002 20150715
/2016	Austria		PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND ATAZANAVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE ATAZANAVIR-SULFAT; REGISTRATION NO/DATE: EU/1/15/1025 (MITTEILUNG) 20150715